Difference between revisions of "Harry Kuiper"
| Line 2: | Line 2: | ||
A 2010 report from German NGO TestBiotech noted: | A 2010 report from German NGO TestBiotech noted: | ||
| − | :Harry Kuiper, and a second expert from the same panel, [[Gijs Kleter]], have for years been working with the [[International Life | + | :Harry Kuiper, and a second expert from the same panel, [[Gijs Kleter]], have for years been working with the [[International Life Sciences Institute]] (ILSI). They cooperate with representatives of companies such as [[Monsanto]], [[DuPont]], [[Dow AgroSciences]], [[Syngenta]] and [[Bayer]], within projects that aim to soften criteria for risk assessment for genetically engineered plants.<ref>TestBiotech, 2010. [http://www.testbiotech.org/en/node/426 EFSA: a playing field for biotech industry], acc 26 Mar 2011</ref> |
==Affiliations== | ==Affiliations== | ||
Revision as of 18:57, 9 January 2012
Harry Kuiper has been chair since 2003 of the European Food Safety Authority GMO Panel, the group of experts responsible for the risk assessment of genetically modified (GM) crops.[1]
A 2010 report from German NGO TestBiotech noted:
- Harry Kuiper, and a second expert from the same panel, Gijs Kleter, have for years been working with the International Life Sciences Institute (ILSI). They cooperate with representatives of companies such as Monsanto, DuPont, Dow AgroSciences, Syngenta and Bayer, within projects that aim to soften criteria for risk assessment for genetically engineered plants.[2]
Contents
Affiliations
Contact
- Address:
- ...
- ...
- ...
- ...
- Phone:
- ...
- Email:
- ...
- Website:
- ...
Resources
Notes
- ↑ EFSA, 2009. Opinion of the Scientific Committee/Scientific Panel on Application (Reference EFSA-GMO-UK-2005-11) for the placing on the market of insect-resistant genetically modified maize MIR604 event, for food and feed uses, import and processing under Regulation (EC) No 1829/2003 from Syngenta Seeds S.A.S on behalf of Syngenta Crop Protection AG, EFSA Journal, 21 July 2009
- ↑ TestBiotech, 2010. EFSA: a playing field for biotech industry, acc 26 Mar 2011
